Cargando…
Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
AIMS: Although the number of patients suffering from heart failure with preserved ejection fraction (HFpEF) increases, the routine diagnosis remains a challenge. In the absence of a pathognomonic sign for HFpEF or specific treatment strategies, a prognosis‐based characterization of suspected patient...
Autores principales: | Hashemi, Djawid, Mende, Meinhard, Trippel, Tobias D., Petutschnigg, Johannes, Hasenfuss, Gerd, Nolte, Kathleen, Herrmann‐Lingen, Christoph, Feuerstein, Anna, Langhammer, Romy, Tschöpe, Carsten, Pieske, Burkert, Wachter, Rolf, Edelmann, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773646/ https://www.ncbi.nlm.nih.gov/pubmed/36070881 http://dx.doi.org/10.1002/ehf2.14131 |
Ejemplares similares
-
The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study
por: Trippel, Tobias Daniel, et al.
Publicado: (2021) -
Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study
por: Stahrenberg, Raoul, et al.
Publicado: (2015) -
Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
por: Meyer, Thomas, et al.
Publicado: (2015) -
Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study
por: Eidizadeh, Abass, et al.
Publicado: (2022) -
Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
por: Hashemi, Djawid, et al.
Publicado: (2020)